Amotio key facts
- Developer of a personalized technological approach intended for orthopedic revision surgery and bone cement removal.
- It has raised $810K; the latest was Early Stage VC ($810K) in Jul 2025.
- Notable investors include Development Bank of Wales, NLC Health Ventures, Utrecht Holdings, Orthopaedic Research UK.
- Status: Privately Held (backing).
- ·Watch Amotio: the Monday email on marks, rounds and moves
Amotio funding rounds
No funding rounds for Amotio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Amotio investors
4 investors are on record for Amotio, including Development Bank of Wales, NLC Health Ventures, Utrecht Holdings and Orthopaedic Research UK.
About Amotio
Developer of a personalized technological approach intended for orthopedic revision surgery and bone cement removal. The company develops a patient-specific, precision-based procedure for bone cement removal in major joint revision surgery through digital joint mapping, templating and surgical planning, patent-specific intelligent surgical guide printing, and a precision-guided bone cement removal device, enabling patients to have better outcomes and quality of life, shorter surgical time and reduced cost burden to health care providers.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2022
- Website
- amotio.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Amotio doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.